Effectiveness of Postoperative Adjuvant Therapy with Cytotoxic Chemotherapy (Cytosine Arabinoside, Mitomycin C, 5-Fluorouracil) or Immunotherapy (Neuraminidase-Modified Allogeneic Cells) in the ... View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

1981

AUTHORS

H. Rainer , E. Kovats , H. G. Lehmann , M. Micksche , R. Rauhs , H. H. Sedlacek , W. Seidl , M. Schemper , R. Schiessel , B. Schweiger , M. Wunderlich

ABSTRACT

Even after complete resection of all detectable tumor, the prognosis of patients with Duke’s B or C carcinoma of the large bowel is poor. As “curative” surgery alone often proves inadequate, many types of postoperative adjuvant procedures have been applied in an attempt to improve the long-term survival rates. Systemic adjuvant therapy generally consists of either chemotherapy or immunotherapy, and after radical surgery, the 5-year survival rates are roughly 80% for Duke’s B and 30%–60% for Duke’s C cases [1]. In view of these statistics, application of a postopertive adjuvant therapy appears to be the most rational choice [2]. More... »

PAGES

41-7

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-3-642-81681-9_5

DOI

http://dx.doi.org/10.1007/978-3-642-81681-9_5

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1037682386

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/6795698


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Colonic Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cytarabine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fluorouracil", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunotherapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mitomycin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mitomycins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Recurrence, Local", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neuraminidase", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vaccination", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Universit\u00e4tsklinik f\u00fcr Chemotherapy, Lazarettgasse 14, A-1090\u00a0Wien, Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rainer", 
        "givenName": "H.", 
        "id": "sg:person.01012351665.80", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01012351665.80"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Universit\u00e4tsklinik f\u00fcr Chemotherapy, Lazarettgasse 14, A-1090\u00a0Wien, Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kovats", 
        "givenName": "E.", 
        "id": "sg:person.01330512457.91", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01330512457.91"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Universit\u00e4tsklinik f\u00fcr Chemotherapy, Lazarettgasse 14, A-1090\u00a0Wien, Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lehmann", 
        "givenName": "H. G.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Universit\u00e4tsklinik f\u00fcr Chemotherapy, Lazarettgasse 14, A-1090\u00a0Wien, Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Micksche", 
        "givenName": "M.", 
        "id": "sg:person.0113344550.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0113344550.13"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Universit\u00e4tsklinik f\u00fcr Chemotherapy, Lazarettgasse 14, A-1090\u00a0Wien, Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rauhs", 
        "givenName": "R.", 
        "id": "sg:person.066646264.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.066646264.21"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Universit\u00e4tsklinik f\u00fcr Chemotherapy, Lazarettgasse 14, A-1090\u00a0Wien, Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sedlacek", 
        "givenName": "H. H.", 
        "id": "sg:person.0626371251.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0626371251.49"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Universit\u00e4tsklinik f\u00fcr Chemotherapy, Lazarettgasse 14, A-1090\u00a0Wien, Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Seidl", 
        "givenName": "W.", 
        "id": "sg:person.0674504451.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0674504451.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Universit\u00e4tsklinik f\u00fcr Chemotherapy, Lazarettgasse 14, A-1090\u00a0Wien, Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schemper", 
        "givenName": "M.", 
        "id": "sg:person.01133613667.46", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01133613667.46"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Universit\u00e4tsklinik f\u00fcr Chemotherapy, Lazarettgasse 14, A-1090\u00a0Wien, Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schiessel", 
        "givenName": "R.", 
        "id": "sg:person.01314616041.50", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01314616041.50"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Universit\u00e4tsklinik f\u00fcr Chemotherapy, Lazarettgasse 14, A-1090\u00a0Wien, Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schweiger", 
        "givenName": "B.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Universit\u00e4tsklinik f\u00fcr Chemotherapy, Lazarettgasse 14, A-1090\u00a0Wien, Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wunderlich", 
        "givenName": "M.", 
        "id": "sg:person.01145215475.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01145215475.25"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf00199623", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047693077", 
          "https://doi.org/10.1007/bf00199623"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00199623", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047693077", 
          "https://doi.org/10.1007/bf00199623"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1981", 
    "datePublishedReg": "1981-01-01", 
    "description": "Even after complete resection of all detectable tumor, the prognosis of patients with Duke\u2019s B or C carcinoma of the large bowel is poor. As \u201ccurative\u201d surgery alone often proves inadequate, many types of postoperative adjuvant procedures have been applied in an attempt to improve the long-term survival rates. Systemic adjuvant therapy generally consists of either chemotherapy or immunotherapy, and after radical surgery, the 5-year survival rates are roughly 80% for Duke\u2019s B and 30%\u201360% for Duke\u2019s C cases [1]. In view of these statistics, application of a postopertive adjuvant therapy appears to be the most rational choice [2].", 
    "editor": [
      {
        "familyName": "Klein", 
        "givenName": "Hans Otto", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-3-642-81681-9_5", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-3-642-81683-3", 
        "978-3-642-81681-9"
      ], 
      "name": "Chemotherapy and Radiotherapy of Gastrointestinal Tumors", 
      "type": "Book"
    }, 
    "name": "Effectiveness of Postoperative Adjuvant Therapy with Cytotoxic Chemotherapy (Cytosine Arabinoside, Mitomycin C, 5-Fluorouracil) or Immunotherapy (Neuraminidase-Modified Allogeneic Cells) in the Prevention of Recurrence of Duke\u2019s B and C Colon Cancer", 
    "pagination": "41-7", 
    "productId": [
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-3-642-81681-9_5"
        ]
      }, 
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "b381b4b657af065c5d64316ebe0956531dea6707f36f3e55006331a350ae8091"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1037682386"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "6795698"
        ]
      }
    ], 
    "publisher": {
      "location": "Berlin, Heidelberg", 
      "name": "Springer Berlin Heidelberg", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-3-642-81681-9_5", 
      "https://app.dimensions.ai/details/publication/pub.1037682386"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2019-04-15T17:15", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8678_00000266.jsonl", 
    "type": "Chapter", 
    "url": "http://link.springer.com/10.1007/978-3-642-81681-9_5"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-3-642-81681-9_5'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-3-642-81681-9_5'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-3-642-81681-9_5'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-3-642-81681-9_5'


 

This table displays all metadata directly associated to this object as RDF triples.

216 TRIPLES      23 PREDICATES      43 URIs      35 LITERALS      23 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-3-642-81681-9_5 schema:about N042538101dcf47a399b9f50d7e16660d
2 N06b873d5dee048718124121119e409e1
3 N3e188b49fb9e433b8ff66c1fce5ecee3
4 N3f119d2b850247908a40148215f6f7fc
5 N42b91e38a50847589103eaa9eb0d47f5
6 N497781116ef54792bbb0280742783843
7 N55822db8d550467e9638c2133a09bd1d
8 N67d7654bc0464791b68a2d8118587314
9 N6cdbd6e7221d4425898215a84a0a0864
10 N6f2785629e4f464f8f3dc2af95648e6f
11 N97b7dcb8d70f4c6fb36932cb224aa8ed
12 Nb26fca824f0948e7ae30bab651c92d7c
13 Nf5974ae05b1844a0831d20934513163d
14 Nf98aaa7ead3945588b64fc14bd6bf6c6
15 anzsrc-for:11
16 anzsrc-for:1112
17 schema:author N6a0cfc2f60e949a6bba9c034f0ac3920
18 schema:citation sg:pub.10.1007/bf00199623
19 schema:datePublished 1981
20 schema:datePublishedReg 1981-01-01
21 schema:description Even after complete resection of all detectable tumor, the prognosis of patients with Duke’s B or C carcinoma of the large bowel is poor. As “curative” surgery alone often proves inadequate, many types of postoperative adjuvant procedures have been applied in an attempt to improve the long-term survival rates. Systemic adjuvant therapy generally consists of either chemotherapy or immunotherapy, and after radical surgery, the 5-year survival rates are roughly 80% for Duke’s B and 30%–60% for Duke’s C cases [1]. In view of these statistics, application of a postopertive adjuvant therapy appears to be the most rational choice [2].
22 schema:editor Nc95c229345ca42e8aca57d596b772774
23 schema:genre chapter
24 schema:inLanguage en
25 schema:isAccessibleForFree false
26 schema:isPartOf Ne1eac5199ea94b9184fbfbf09a1e267c
27 schema:name Effectiveness of Postoperative Adjuvant Therapy with Cytotoxic Chemotherapy (Cytosine Arabinoside, Mitomycin C, 5-Fluorouracil) or Immunotherapy (Neuraminidase-Modified Allogeneic Cells) in the Prevention of Recurrence of Duke’s B and C Colon Cancer
28 schema:pagination 41-7
29 schema:productId N16677a4331814987b502ab3cd074a4f8
30 N8f5454569cc547a7a98e363dd6288335
31 Nd8403c6c3633484e934af7badf8e0eb6
32 Ne14fb0679d044355b4e2c7b470175851
33 schema:publisher N9cc1d5dd602943d593b0d9e036589af8
34 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037682386
35 https://doi.org/10.1007/978-3-642-81681-9_5
36 schema:sdDatePublished 2019-04-15T17:15
37 schema:sdLicense https://scigraph.springernature.com/explorer/license/
38 schema:sdPublisher N4ad6023991f543fcbd6d76e8e532de49
39 schema:url http://link.springer.com/10.1007/978-3-642-81681-9_5
40 sgo:license sg:explorer/license/
41 sgo:sdDataset chapters
42 rdf:type schema:Chapter
43 N018c20ba47484058ab0055b86c09c9ed rdf:first sg:person.01145215475.25
44 rdf:rest rdf:nil
45 N042538101dcf47a399b9f50d7e16660d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
46 schema:name Neoplasm Recurrence, Local
47 rdf:type schema:DefinedTerm
48 N06b873d5dee048718124121119e409e1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
49 schema:name Middle Aged
50 rdf:type schema:DefinedTerm
51 N08171449876a4bbdaf53b2e5816a4f38 rdf:first N2360d16c890744f3b52cc8119823083d
52 rdf:rest N018c20ba47484058ab0055b86c09c9ed
53 N16677a4331814987b502ab3cd074a4f8 schema:name dimensions_id
54 schema:value pub.1037682386
55 rdf:type schema:PropertyValue
56 N19e3366f63fb4cd6a6f97b7d1168da93 rdf:first sg:person.0626371251.49
57 rdf:rest Na5a0638f428e42e2834bbb2b1241966b
58 N2360d16c890744f3b52cc8119823083d schema:affiliation Nb3fca30ecffd4f6792613be20c4d8b2f
59 schema:familyName Schweiger
60 schema:givenName B.
61 rdf:type schema:Person
62 N237232afc0bb483e9b49bbf17c2e1a0b schema:familyName Klein
63 schema:givenName Hans Otto
64 rdf:type schema:Person
65 N2ecfcc94ff444305ae7a3f513402fd3d rdf:first sg:person.01330512457.91
66 rdf:rest Nf02306ec5ec946548e113ba74b80ab11
67 N3be1f44ab27e44afb3a6c2fce6999f81 schema:name Universitätsklinik für Chemotherapy, Lazarettgasse 14, A-1090 Wien, Austria
68 rdf:type schema:Organization
69 N3c2a3a3752f94a3ca02a072fd665b2db schema:affiliation N60aa7ed1e58d4827a5656901b75079d2
70 schema:familyName Lehmann
71 schema:givenName H. G.
72 rdf:type schema:Person
73 N3e188b49fb9e433b8ff66c1fce5ecee3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
74 schema:name Immunotherapy
75 rdf:type schema:DefinedTerm
76 N3f119d2b850247908a40148215f6f7fc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
77 schema:name Neuraminidase
78 rdf:type schema:DefinedTerm
79 N40658020b03548c1b10205d56ce8b3ad schema:name Universitätsklinik für Chemotherapy, Lazarettgasse 14, A-1090 Wien, Austria
80 rdf:type schema:Organization
81 N42b91e38a50847589103eaa9eb0d47f5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
82 schema:name Colonic Neoplasms
83 rdf:type schema:DefinedTerm
84 N487c4b8e351346e88f4c999e117177ca schema:name Universitätsklinik für Chemotherapy, Lazarettgasse 14, A-1090 Wien, Austria
85 rdf:type schema:Organization
86 N497781116ef54792bbb0280742783843 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
87 schema:name Mitomycin
88 rdf:type schema:DefinedTerm
89 N4ad6023991f543fcbd6d76e8e532de49 schema:name Springer Nature - SN SciGraph project
90 rdf:type schema:Organization
91 N55822db8d550467e9638c2133a09bd1d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Cytarabine
93 rdf:type schema:DefinedTerm
94 N60aa7ed1e58d4827a5656901b75079d2 schema:name Universitätsklinik für Chemotherapy, Lazarettgasse 14, A-1090 Wien, Austria
95 rdf:type schema:Organization
96 N67d7654bc0464791b68a2d8118587314 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name Aged
98 rdf:type schema:DefinedTerm
99 N6a0cfc2f60e949a6bba9c034f0ac3920 rdf:first sg:person.01012351665.80
100 rdf:rest N2ecfcc94ff444305ae7a3f513402fd3d
101 N6cdbd6e7221d4425898215a84a0a0864 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Fluorouracil
103 rdf:type schema:DefinedTerm
104 N6f2785629e4f464f8f3dc2af95648e6f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Mitomycins
106 rdf:type schema:DefinedTerm
107 N70a1a61a5eee49e898df5e0c4ec485e1 schema:name Universitätsklinik für Chemotherapy, Lazarettgasse 14, A-1090 Wien, Austria
108 rdf:type schema:Organization
109 N719d64e2616a4ad887bad437a3602f9d schema:name Universitätsklinik für Chemotherapy, Lazarettgasse 14, A-1090 Wien, Austria
110 rdf:type schema:Organization
111 N77ef0842d020424aa49e8e5bd43bbcb7 schema:name Universitätsklinik für Chemotherapy, Lazarettgasse 14, A-1090 Wien, Austria
112 rdf:type schema:Organization
113 N7d0aaf3d6054466890597efd6f4859ba schema:name Universitätsklinik für Chemotherapy, Lazarettgasse 14, A-1090 Wien, Austria
114 rdf:type schema:Organization
115 N8f5454569cc547a7a98e363dd6288335 schema:name pubmed_id
116 schema:value 6795698
117 rdf:type schema:PropertyValue
118 N97b7dcb8d70f4c6fb36932cb224aa8ed schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Female
120 rdf:type schema:DefinedTerm
121 N9cc1d5dd602943d593b0d9e036589af8 schema:location Berlin, Heidelberg
122 schema:name Springer Berlin Heidelberg
123 rdf:type schema:Organisation
124 N9e8aa8aff662461db8bf159e5a4b10f9 rdf:first sg:person.01133613667.46
125 rdf:rest Nb5f26aee4e144262a2297757a064200b
126 Na5a0638f428e42e2834bbb2b1241966b rdf:first sg:person.0674504451.36
127 rdf:rest N9e8aa8aff662461db8bf159e5a4b10f9
128 Nb26fca824f0948e7ae30bab651c92d7c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Humans
130 rdf:type schema:DefinedTerm
131 Nb3fca30ecffd4f6792613be20c4d8b2f schema:name Universitätsklinik für Chemotherapy, Lazarettgasse 14, A-1090 Wien, Austria
132 rdf:type schema:Organization
133 Nb5f26aee4e144262a2297757a064200b rdf:first sg:person.01314616041.50
134 rdf:rest N08171449876a4bbdaf53b2e5816a4f38
135 Nc17c03d396b0459285b38be8cbaf823a rdf:first sg:person.0113344550.13
136 rdf:rest Nfbefa4f5c3b4436480d98afdf05ff94a
137 Nc64a4b54e21a4e888718b0004908951f schema:name Universitätsklinik für Chemotherapy, Lazarettgasse 14, A-1090 Wien, Austria
138 rdf:type schema:Organization
139 Nc95c229345ca42e8aca57d596b772774 rdf:first N237232afc0bb483e9b49bbf17c2e1a0b
140 rdf:rest rdf:nil
141 Nd8403c6c3633484e934af7badf8e0eb6 schema:name doi
142 schema:value 10.1007/978-3-642-81681-9_5
143 rdf:type schema:PropertyValue
144 Ndf347227389344f4b05e17b111f7ead0 schema:name Universitätsklinik für Chemotherapy, Lazarettgasse 14, A-1090 Wien, Austria
145 rdf:type schema:Organization
146 Ne14fb0679d044355b4e2c7b470175851 schema:name readcube_id
147 schema:value b381b4b657af065c5d64316ebe0956531dea6707f36f3e55006331a350ae8091
148 rdf:type schema:PropertyValue
149 Ne1eac5199ea94b9184fbfbf09a1e267c schema:isbn 978-3-642-81681-9
150 978-3-642-81683-3
151 schema:name Chemotherapy and Radiotherapy of Gastrointestinal Tumors
152 rdf:type schema:Book
153 Nf02306ec5ec946548e113ba74b80ab11 rdf:first N3c2a3a3752f94a3ca02a072fd665b2db
154 rdf:rest Nc17c03d396b0459285b38be8cbaf823a
155 Nf5974ae05b1844a0831d20934513163d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Male
157 rdf:type schema:DefinedTerm
158 Nf98aaa7ead3945588b64fc14bd6bf6c6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Vaccination
160 rdf:type schema:DefinedTerm
161 Nfbefa4f5c3b4436480d98afdf05ff94a rdf:first sg:person.066646264.21
162 rdf:rest N19e3366f63fb4cd6a6f97b7d1168da93
163 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
164 schema:name Medical and Health Sciences
165 rdf:type schema:DefinedTerm
166 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
167 schema:name Oncology and Carcinogenesis
168 rdf:type schema:DefinedTerm
169 sg:person.01012351665.80 schema:affiliation Ndf347227389344f4b05e17b111f7ead0
170 schema:familyName Rainer
171 schema:givenName H.
172 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01012351665.80
173 rdf:type schema:Person
174 sg:person.0113344550.13 schema:affiliation N40658020b03548c1b10205d56ce8b3ad
175 schema:familyName Micksche
176 schema:givenName M.
177 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0113344550.13
178 rdf:type schema:Person
179 sg:person.01133613667.46 schema:affiliation Nc64a4b54e21a4e888718b0004908951f
180 schema:familyName Schemper
181 schema:givenName M.
182 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01133613667.46
183 rdf:type schema:Person
184 sg:person.01145215475.25 schema:affiliation N3be1f44ab27e44afb3a6c2fce6999f81
185 schema:familyName Wunderlich
186 schema:givenName M.
187 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01145215475.25
188 rdf:type schema:Person
189 sg:person.01314616041.50 schema:affiliation N487c4b8e351346e88f4c999e117177ca
190 schema:familyName Schiessel
191 schema:givenName R.
192 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01314616041.50
193 rdf:type schema:Person
194 sg:person.01330512457.91 schema:affiliation N77ef0842d020424aa49e8e5bd43bbcb7
195 schema:familyName Kovats
196 schema:givenName E.
197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01330512457.91
198 rdf:type schema:Person
199 sg:person.0626371251.49 schema:affiliation N719d64e2616a4ad887bad437a3602f9d
200 schema:familyName Sedlacek
201 schema:givenName H. H.
202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0626371251.49
203 rdf:type schema:Person
204 sg:person.066646264.21 schema:affiliation N7d0aaf3d6054466890597efd6f4859ba
205 schema:familyName Rauhs
206 schema:givenName R.
207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.066646264.21
208 rdf:type schema:Person
209 sg:person.0674504451.36 schema:affiliation N70a1a61a5eee49e898df5e0c4ec485e1
210 schema:familyName Seidl
211 schema:givenName W.
212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0674504451.36
213 rdf:type schema:Person
214 sg:pub.10.1007/bf00199623 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047693077
215 https://doi.org/10.1007/bf00199623
216 rdf:type schema:CreativeWork
 




Preview window. Press ESC to close (or click here)


...